Wnt7b Expression in Bladder Cancer
Author Information
Author(s): TD Bui, T O'Brien, J Crew, D Cranston, AL Harris
Primary Institution: Imperial Cancer Research Fund, University of Oxford
Hypothesis
The study investigates whether factors upstream of cadherins are aberrantly expressed in superficial bladder cancer.
Conclusion
Wnt7b is highly expressed in superficial bladder tumors compared to normal tissues and invasive tumors, suggesting its role in early bladder tumorigenesis.
Supporting Evidence
- The median expression of Wnt7b was fourfold higher in superficial tumors than in normal tissues.
- Wnt7b expression was fivefold higher in superficial tumors compared to invasive tumors.
- There was no significant difference in Wnt5a expression between normal and tumor tissues.
Takeaway
This study found that a gene called Wnt7b is much more active in early bladder cancers than in normal bladder tissue or more advanced cancers.
Methodology
The expression of Wnt7b and Wnt5a was analyzed in bladder carcinoma cell lines and tissues using ribonuclease protection analysis.
Limitations
The study may not account for tissue heterogeneity affecting gene expression results.
Participant Demographics
Included 8 normal bladder tissues and 48 bladder cancer samples, with 29 superficial and 17 invasive tumors.
Statistical Information
P-Value
0.002 for superficial vs normal, 0.003 for superficial vs invasive
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website